Weekly glucagon‐like peptide‐1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled study

AIMS/INTRODUCTION: The present phase 3, randomized, double‐blind 24‐week study with extension to 1 year assessed the efficacy and safety of albiglutide compared with placebo in Japanese patients with type 2 diabetes mellitus inadequately controlled by diet and exercise with or without a single oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Nino, Antonio, Okuda, Inaha, Wilson, Timothy H, Yue, Lynn, Nakajima, Hiromu, Tsuboi, Maho, Carr, Molly C, Seino, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934244/
https://www.ncbi.nlm.nih.gov/pubmed/28921915
http://dx.doi.org/10.1111/jdi.12749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934244/
https://www.ncbi.nlm.nih.gov/pubmed/28921915
http://dx.doi.org/10.1111/jdi.12749

Ejemplares similares